<DOC>
	<DOCNO>NCT00806013</DOCNO>
	<brief_summary>The aim study investigate effect CYP2C9 CYP2C19 polymorphisms pharmacokinetics pharmacodynamics glipizide healthy Chinese subject .</brief_summary>
	<brief_title>Study Effects CYP2C Polymorphisms Pharmacokinetics Pharmacodynamics Glipizide</brief_title>
	<detailed_description>Compared CYP2C19 , CYP2C9 polymorphism appear dominant role glipizide pharmacokinetics pharmacodynamics vivo . This indicate dose adjustment base CYP2C9 genotype may improve antidiabetic treatment .</detailed_description>
	<mesh_term>Glipizide</mesh_term>
	<criteria>nonsmoker good health family history diabetes mellitus take drug , alcohol , food contain caffeine , grapefruit juice study</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>27 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>genotype</keyword>
</DOC>